Literature DB >> 7501100

Pineoblastoma in adults.

S M Chang1, P K Lillis-Hearne, D A Larson, W M Wara, A W Bollen, M D Prados.   

Abstract

This is the first report of a series of adults (> 16 years of age) with pineoblastomas who had their entire neuraxis staged at the time of diagnosis. Between 1975 and 1992, seven men and four women with histologically proven pineoblastomas were evaluated at the University of California, San Francisco. The median age at diagnosis was 36 years (range, 17-59 yr). All patients presented with symptomatic hydrocephalus. One patient had a complete surgical resection, eight had subtotal resections, and two had biopsies only. One patient refused any treatment or follow-up review and died 6 months after diagnosis. The five patients with positively staged disease had progression either focally or in the spine 8 to 49 months (median, 10 mo) after initial diagnosis and died 1 to 20 months after recurrence; the median overall survival time from the date of surgery was 30 months. In contrast, all five patients with negatively staged disease were alive without disease progression after a median of 26 months of follow-up. Our retrospective review shows that the extent of disease at diagnosis seems to be an important prognostic factor for pineoblastomas, as is true for medulloblastomas and other primitive neuroectodermal tumors. Initial staging should include examination of the cerebrospinal fluid and magnetic resonance imaging of the spine. Although patients with pineoblastomas are often treated with adjuvant systemic chemotherapy after craniospinal irradiation, the benefits of this approach are unclear.

Entities:  

Mesh:

Year:  1995        PMID: 7501100     DOI: 10.1227/00006123-199509000-00003

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  16 in total

1.  Childhood pineal parenchymal tumors: clinical and therapeutic aspects.

Authors:  Marek Mandera; Wiesław Marcol; Katarzyna Kotulska; Edyta Olakowska; Dariusz Gołka; Izabela Malinowska; Marita Pietrucha-Dutczak; Marek Olakowski; Joanna Lewin-Kowalik
Journal:  Neurosurg Rev       Date:  2010-10-06       Impact factor: 3.042

2.  Pineal parenchymal tumors. Management with interstitial iodine-125 radiosurgery.

Authors:  Mohammad Maarouf; Faycal El Majdoub; Christian Bührle; Jürgen Voges; Ralph Lehrke; Martin Kocher; Stefan Hunsche; Harald Treuer; Volker Sturm
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

3.  Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol.

Authors:  Carsten Friedrich; Klaus Müller; Katja von Hoff; Robert Kwiecien; Torsten Pietsch; Monika Warmuth-Metz; Nicolas U Gerber; Peter Hau; Joachim Kuehl; Rolf D Kortmann; André O von Bueren; Stefan Rutkowski
Journal:  J Neurooncol       Date:  2014-01-10       Impact factor: 4.130

Review 4.  Microsurgical resection of pineal region tumors.

Authors:  Adam M Sonabend; Stephen Bowden; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2016-05-19       Impact factor: 4.130

5.  Outcome and prognostic features in paediatric pineoblastomas: analysis of cases from the Surveillance, Epidemiology, and End Results registry (1990-2007).

Authors:  Senthil K Selvanathan; Oliver Richards; Saira Alli; Martin Elliott; Atul K Tyagi; Paul D Chumas
Journal:  Acta Neurochir (Wien)       Date:  2019-05-18       Impact factor: 2.216

6.  Complete regression of adult pineoblastoma following radiotherapy: A case report and review of the literature.

Authors:  Ping Ai; Xingchen Peng; Yong Jiang; Hong Zhang; Shichao Wang; Yuquan Wei
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

7.  Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.

Authors:  Christian L Barney; Aaron P Brown; David R Grosshans; Mary Frances McAleer; John F de Groot; Vinay Puduvalli; Susan L Tucker; Cody N Crawford; Mark R Gilbert; Paul D Brown; Anita Mahajan
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

8.  Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN).

Authors:  Salvador Villà; Robert C Miller; Marco Krengli; Huda Abusaris; Brigitta G Baumert; Stephanie Servagi-Vernat; Sefik Igdem; Anna Lucas; Susanna Boluda; René O Mirimanoff
Journal:  Clin Transl Oncol       Date:  2012-08-23       Impact factor: 3.405

9.  Response of an adult patient with pineoblastoma to vorinostat and retinoic acid.

Authors:  Rebecca DeBoer; Hunt Batjer; Maryanne Marymont; Stewart Goldman; Matthew Walker; Numa Gottardi-Littell; Jeffrey Raizer
Journal:  J Neurooncol       Date:  2009-06-09       Impact factor: 4.130

10.  Pineal parenchymal tumor of intermediate differentiation: diagnostic pitfalls and discussion of treatment options of a rare tumor entity.

Authors:  Christian Senft; Andreas Raabe; Elke Hattingen; Daniel Sommerlad; Volker Seifert; Kea Franz
Journal:  Neurosurg Rev       Date:  2008-02-12       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.